Rehabilitation of children with progressive muscular dystrophy Duchenne

Rehabilitation of children with progressive muscular dystrophy Duchenne

Duchenne muscular dystrophy is the most common form of myodystrophy characterized by muscle weakness and atrophy and a progressive course due to progressive muscle fiber degeneration. Until now, this disease is regarded as incurable. Patients receive only maintenance therapy aimed at improving the q...

Full description

Bibliographic Details
Main Authors:	N. Yu. Nikolenko, O. V. Goncharova, S. B. Artemyeva, E. E. Achkasov, E. B. Litvinova
Format:	Article
Language:	Russian
Published:	Ltd. “The National Academy of Pediatric Science and Innovation” 2016-03-01
Series:	Rossijskij Vestnik Perinatologii i Pediatrii
Subjects:	children progressive muscular dystrophy duchenne disease pathogenesis clinical manifestations rehabilitation physical exercises
Online Access:	https://www.ped-perinatology.ru/jour/article/view/55

Similar Items

Rehabilitation therapy of Duchenne muscular dystrophy
by: Cheng ZHANG, et al.
Published: (2012-06-01)

CARDIAC COMPLICATIONS IN DUCHENNE MUSCULAR DYSTROPHY IN CHILDREN
by: Ioana Grigore, et al.
Published: (2015-12-01)

Progressive Muscular Dystrophy (Duchenne Type) (Case Report)
by: Soelatin Winarno, et al.
Published: (2019-09-01)

Duchenne muscular dystrophy: an historical treatment review
by: Lineu Cesar Werneck, et al.

Mitochondrial disorders in progressive muscular dystrophies
by: D. A. Kharlamov, et al.
Published: (2016-03-01)

Strengthen the research of Duchenne muscular dystrophy in China
by: Cheng ZHANG
Published: (2015-06-01)

Progressive muscular dystrophy: Duchenne type. Controversies of the kinesitherapy treatment
by: Ana Valéria de Araujo Leitão, et al.

Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update
by: Chengmei Sun, et al.
Published: (2020-07-01)

Natural history of Duchenne muscular dystrophy
by: Qing KE, et al.
Published: (2015-05-01)

Duchenne and Becker muscular dystrophy: implications for at-risk individuals
by: Erasmus, Suretha
Published: (2010)

Glucocorticoids for Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (2013-07-01)

Tracking disease progression non‐invasively in Duchenne and Becker muscular dystrophies
by: Pietro Spitali, et al.
Published: (2018-08-01)

Progress study of the cardiac damage in Duchenne muscular dystrophy
by: Yao ZHANG, et al.
Published: (2013-05-01)

Pain characterization in Duchenne muscular dystrophy
by: Talita Dias da Silva, et al.

Research advance and application prospect of therapeutic strategies for Duchenne muscular dystrophy
by: Cheng ZHANG, et al.
Published: (2018-07-01)

Review the history of Duchenne muscular dystrophy and seize the cutting-edge research
by: Cheng ZHANG
Published: (2015-05-01)

The research status and problems of Duchenne muscular dystrophy in China
by: Cheng ZHANG, et al.
Published: (2018-07-01)

The evolution of electrocardiographic changes in patients with Duchenne muscular dystrophies
by: Woo Hyun Yoo, et al.
Published: (2017-06-01)

Muscular Fatigue in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1995-02-01)

Mutation detection and the use of tissue expression profiling to elucidate the pathogenesis of Duchenne Muscular Dystrophy.
by: Hallwirth Pillay, Kumari Devi.
Published: (2014)

Yesterday, today and tomorrow of Duchenne muscular dystrophy
by: Cheng ZHANG
Published: (2015-05-01)

Molecular Mechanisms that Underlie Duchenne Muscular Dystrophy
by: Babaria, Arati
Published: (2016)

Duchenne and Becker muscular dystrophy in adolescents: current perspectives
by: Andrews JG, et al.
Published: (2018-03-01)

Motor clinical progression in a series of pediatric Duchenne and Becker muscular dystrophy cases
by: Zakiah Nur Istianah, et al.
Published: (2019-03-01)

Research progress of motor function assessments and their clinical applications in Duchenne muscular dystrophy
by: Wei SHI
Published: (2015-06-01)

Early Development in Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1990-07-01)

Advance and cogitation of gene therapy for Duchenne muscular dystrophy
by: Cheng ZHANG, et al.
Published: (2019-05-01)

Prepare for the era of gene therapy for Duchenne muscular dystrophy
by: Cheng ZHANG
Published: (2019-05-01)

A comprehensive database of Duchenne and Becker muscular dystrophy patients in Children's Hospital of Fudan University
by: Xi-hua LI, et al.
Published: (2015-05-01)

Nutraceuticals and Their Potential to Treat Duchenne Muscular Dystrophy: Separating the Credible from the Conjecture
by: Keryn G. Woodman, et al.
Published: (2016-11-01)

Diagnosis delay of Duchenne Muscular Dystrophy Demora no diagnóstico da Distrofia Muscular de Duchenne
by: Alexandra Prufer de Queiroz Campos Araújo, et al.
Published: (2004-06-01)

Cardiomyopathy secondary to Duchenne muscular dystrophy in children
by: Iulia Rodoman, et al.
Published: (2021-06-01)

Outcome of Long-Term Corticosteroid Treatment in Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (2007-06-01)

A study of diffusion tensor imaging in Duchenne muscular dystrophy
by: Ya FU, et al.
Published: (2015-05-01)

Language Delay in Duchenne’s Muscular Dystrophy
by: J Gordon Millichap
Published: (2007-06-01)

Brain Function in Duchenne Muscular Dystrophy
by: J. Gordon Millichap
Published: (2002-02-01)

The golden retriever model of Duchenne muscular dystrophy
by: Joe N. Kornegay
Published: (2017-05-01)

Validation of Chemokine Biomarkers in Duchenne Muscular Dystrophy
by: Michael Ogundele, et al.
Published: (2021-08-01)

Variability and trends in corticosteroid use by male United States participants with Duchenne muscular dystrophy in the Duchenne Registry
by: Leslie Cowen, et al.
Published: (2019-05-01)

Detection of the mutation may guide treatment of heart and muscle in Duchenne muscular dystrophy
by: Finsterer J, et al.
Published: (2016-03-01)